SENSEX NIFTY
Dishman Pharmaceuticals & Chemicals
BSE: 532526|NSE: DISHMAN|ISIN: INE353G01020|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Feb 12, 16:00
303.90
6.95 (2.34%)
VOLUME 199,236
LIVE
NSE
Feb 12, 15:55
305.30
5.9 (1.97%)
VOLUME 820,585
Stocks attracting Fund Managers
Check out MF Action in another Stock:
SCHEME NAME Dec '15 Sep '15 Jun '15 Mar '15 Dec '14 Sep '14
 
AUM
(Rs. cr.)
No. of
share
%
No. of share No. of share No. of share No. of share No. of share
Birla SL (I) Opportunities (G)97.8047,526 1.66%61,571 - - - -
Birla SL Emer. Leaders-Sr 5-DP (G)0.69275 1.36%291 - - - -
Birla SL Emer. Leaders-Sr 5-RP (G)47.3618,886 1.36%19,900 - - - -
Birla SL Equity Fund -Direct (G)286.40184,747 2.20%142,329 - - - -
Birla SL Manufacturing Equity - DP (G)27.5726,515 3.28%20,676 14,156 9,197 - -
Birla SL Manufacturing Equity - RP (G)918.65883,499 3.28%712,206 501,125 313,632 - -
Birla SL Opportunities -Direct (G)9.834,777 1.66%6,480 - - - -
Birla SL Pure Value - Direct (G)51.0324,389 1.63%12,940 - - - -
Birla SL Pure Value Fund (G)355.19169,758 1.63%90,948 - - - -
Birla SL Special Situat.-Direct (G)1.922,173 3.86%1,986 - - - -
Birla SL Special Situations(G)131.88149,262 3.86%150,886 - - - -
Birla Sun Life Equity Fund (G)2,105.151,357,962 2.20%1,192,490 - - - -
BOI AXA Equity Fund - Direct (G)-- -- - - 281 168
BOI AXA Equity Fund -RP (G)-- -- - - 150,800 35,451
BOI AXA Equity Fund-Eco (G)-- -- - - 911 974
BOI AXA Tax Advantage - Direct (G)-- -- - - - 215
BOI AXA Tax Advtg -Eco (G)-- -- - - - 1,397
BOI AXA Tax Advtg -RP (G)-- -- - - - 21,973
GS CNX 500 Fund (G)58.19511 0.03%377 382 395 493 342
GS CNX 500 Fund - Direct (G)3.9234 0.03%25 24 21 25 17
HDFC Capital Builder - Direct (G)-- -18,958 12,247 - - -
HDFC Capital Builder Fund (G)-- -286,367 344,390 - - -
LIC NOMURA CPOF Sr 1- Direct (G)2.59379 0.50%- - - - -
LIC NOMURA CPOF Sr 1- Regular (G)56.658,292 0.50%- - - - -
LIC NOMURA CPOF Sr 2- Direct (G)1.45200 0.47%- - - - -
LIC NOMURA CPOF Sr 2- Regular (G)48.186,629 0.47%- - - - -
LIC NOMURA CPOF Sr 3- Direct (G)1.45157 0.37%- - - - -
LIC NOMURA CPOF Sr 3- Regular (G)35.933,892 0.37%- - - - -
Sahara Midcap Fund (G)-- -- - - - 3,915
Sahara Midcap Fund - Direct (G)-- -- - - - 5,343
Sahara Star Value Fund (G)-- -- 3,365 3,664 - 2,457
Sahara Star Value Fund -Direct (G)-- -- 740 849 - 1,007
Sahara Taxgain (G)-- -- - - - 11,334
Sahara Taxgain - Direct (G)-- -- - - - 575
Sahara Wealth Plus - FPO (G)-- -- - - - 1,527
Sahara Wealth Plus - VPO (G)-- -- - - - 7,773
Sahara Wealth Plus -FPO -Direct (G)-- -- - - - 36
Sahara Wealth Plus -VPO -Direct (G)-- -- - - - 209
UTI Pharma & Health (G)298.8855,996 0.64%64,152 113,477 105,241 112,114 49,961
UTI Pharma & Health - Direct (G)19.383,631 0.64%3,535 5,428 4,324 4,044 1,662
Total 2,949,490 2,786,117 995,334 437,323 268,668 146,336
Note :
* For schemes that have not disclosed the number of shares, the same has been calculated on the basis of the closing price of the stock on the BSE/NSE as on the portfolio date. The increase/decrease in the share quantity besides the fund buying or selling the shares from the market, could also be due to any bonus, split, rights, or restructuring in the company.
** The numbers in green / red indicate increase /decrease, respectively in the no. of shares over the shares mentioned in the previous month.
PLEASE NOTE : This report is based on the quarter-end portfolios disclosed by AMCs (mutual funds). Starting October 2010, select AMCs have stopped declaring monthly AUM (Assets under Management) and value of the stock in their Portfolio, hence the number of shares for the schemes from these AMCs could not be incorporated in the above report.
For Dec '15, it displays data for 33 out of the total 43 AMCs.
Quick Links for Dishman Pharmaceuticals & Chemicals
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.